(Q44452352)

3 December 2017

title

Evaluation of her-2/neu amplification/overexpression in OSCC with fluorescence in situ hybridization (FISH) and immunohistochemistry (English)

1 reference

3 December 2017

1 reference

1 reference

M Scheer

1

1 reference

3 December 2017

W Prange

2

1 reference

3 December 2017

K Petmecky

3

1 reference

3 December 2017

P Schirmacher

4

1 reference

3 December 2017

J E Zöller

5

1 reference

3 December 2017

A C Kübler

6

1 reference

3 December 2017

language of work or name

German

0 references

publication date

7 March 2003

1 reference

Mund-, Kiefer- und Gesichtschirurgie : MKG

3 December 2017

published in

1 reference

3 December 2017

volume

7

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

138-145

1 reference

describes a project that uses

3 December 2017

fluorescence in situ hybridization

1 reference

HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Multiple essential functions of neuregulin in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

C-erbB-2 Immunostaining in Laryngeal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10006-003-0460-5

C-erbB-2 expression in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

12 December 2020

Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma

1 reference

12 December 2020

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

1 reference

12 December 2020

Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside

1 reference

12 December 2020

Expression of c-erbB-2 gene in human head and neck carcinoma

1 reference

12 December 2020

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up)

1 reference

12 December 2020

Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues

1 reference

12 December 2020

The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer

1 reference

12 December 2020

Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members

1 reference

12 December 2020

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens

1 reference

12 December 2020

The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review).

1 reference

12 December 2020

Basic science of HER-2/neu: a review

1 reference

12 December 2020

p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer.

1 reference

12 December 2020

Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer

1 reference

12 December 2020

Privacy moving into congressional cross hairs

1 reference

12 December 2020

10.1007/S10006-003-0460-5

Identifiers

DOI

1 reference

3 December 2017

1 reference